Skip to main content
Home

Topics navigation

Animals
Climate Crisis
Conflict Regions
Culture
Democracy
Development & Aid
Economy
Education
Energy
Environment
Exemplary People
Food & Agriculture
Globalization
Health
Human Rights
Men
Military
Nature
News Media
Nuclear Disarmament
Peace
Politics
Religions
Social Justice
Sustainability
Women
Youth
Useful Tools
Real News
Events
  • News
Search
  • de
  • / EN

Main navigation

  • Us
    • About Us
    • Endorsements
    • Privacy Policy
    • FAQ
    • Publisher
    • Disclaimer
    • Press
  • You
    • Get Involved
    • What can I do?
    • Add a Link
    • Share knowledge
    • Donate
    • Contact us
Topics Search
  • News

Social Media Links

Bluesky
X
LinkedIn
Facebook
YouTube
Instagram
Tiktok
Switch to German site (opens in a new window)

share

Covaxin (India)

  • Home
  • Health
  • Info by Disease
  • Infections
  • Novel Coronavirus Guide
  • COVID-19 VACCINES
  • Covaxin (India)
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cancel
  • Covaxin / BBV152 - inactivated SARS-CoV-2 / Bharat Biotech - Wikipedia 230299
  • Clinical Trial: Phase 3 Covaxin - CTRI 230872
  • #Covaxin 241908
  • COVID-19 vaccination in India - Wikipedia 241909
  • Covishield-Covaxin mix gives better protection, says ICMR - Hindu 08.09.21 252642
  • How Bharat Biotech’s Vaccine Works - NYT 04.01.21 230683
  • India bars virus vaccine maker from exporting - AP 04.01.21 230570
  • Vacunas contra el coronavirus: la preocupación por la precipitada aprobación de Covaxin, la vacuna desarrollada en India - BBC 04.01.21 230894
  • India’s Vaccine Nationalism Is a Global Risk - Bloomberg 04.01.21 230878
  • Covaxin COVID-19 Vaccine - Precision Vaccination 02.01.21 230879
  • Ocugen and Bharat Biotech to Co-Develop COVAXIN™, a Whole-Virion Inactivated COVID-19 Vaccine, for the US Market - ocugen 22.12.20 230874
  • A Phase 1: Safety and Immunogenicity Trial of an Inactivated SARS-CoV-2 Vaccine-BBV152 - medRXiv 15.12.20 230300
  • India's first COVID-19 vaccine candidate approved for human trials - Reuters 29.06.20 230685
  • DELTA Variant / India - B.1.617
Bluesky
X
LinkedIn
Facebook
YouTube
Instagram
Tiktok
to top
  • About Us
    • FAQ
    • Endorsements
    • Privacy Policy
    • Disclaimer
    • Publisher
    • Press
  • Get Involved
    • What can I do?
    • Add a Link
    • Share knowledge
    • Donate
    • Contact Us
Privacy
Details
Imprint | Privacy
Your selection from
The controller (Dr. Norbert Stute, Austria) would like to use the following services in order to process your personal data. Technologies such as cookies, localStorage, etc. can be used for personalization. This is not necessary for the use of the website, but allows us to interact with you more closely. If you wish, you can adjust or revoke your consent at any time via our privacy policy.
Switch to accept or reject the service